Endocrinology

A randomized trial from the University of Chicago suggests achieving a healthy duration of sleep habitually could reduce energy intake and lead to reductions in body weight.

A recent analysis of data is providing insight into the use of aspirin for preeclampsia prevention among women with prepregnancy obesity, hypertension, or diabetes.

Data from the Teen-LABS study demonstrate undergoing bariatric surgery was associated with an increase in testosterone levels among adolescent males with subnormal serum testosterone levels.

What to know about the efficacy of statin therapies used as cholesterol-lowering therapy.

Approaches to counseling patients with high cholesterol levels on goals of therapy and the role of lifestyle changes as prevention against cardiovascular events.

Results of a recent study shed light on observational and genetic associations between obesity and multiple female reproductive disorders, including uterine fibroids, PCOS, and heavy menstrual bleeding.

Each month, our editorial staff compiles a month in review highlighting the most popular content from the past month. January's month in review features new guidelines, a story on women's health, and more.

Announced on Jan. 28, the Omnipod 5 AID becomes the first tubeless automated insulin delivery system with the ability to integrate with the Dexcom G6 continuous glucose Monitoring System and a compatible smartphone to automatically adjust insulin and protect against glycemic events

There was not an association between sleep duration and metabolic diseases found in men.

Criteria and types of health care professionals who may screen patients at high risk for cardiovascular disease.

Recommendations for establishing relationships and talking with patients about primary and secondary prevention against cardiovascular events.

An analysis of data from more than 135k patients with type 1 and type 2 diabetes indicates the age-adjusted rate of chronic kidney disease was greater in type 1 diabetes and also sheds light on the rising rate of obesity in type 1 diabetes.

The latest endocrine case report from Brady Pregerson, MD, features a man in his mid-70’s with a recent UTI brought to the hospital with a glucose of 30 mg/dL and reports of generalized weakness. Can you determine the correct diagnosis?

New data suggests higher concentrations of NT-proBNP in early pregnancy could help predict women at a lower risk for developing hypertensive disorders of pregnancy and future hypertension.

A comparative effectiveness study of Medicare claims data suggests gastric bypass surgery was associated with a greater rate of discontinuation of medications for obesity-related comorbidities than sleeve gastrectomy.

Out-of-pocket costs for noninsulin medications were 84.4% to 95.2% lower in Medicaid than in Marketplace plans, while out-of-pocket costs for insulin were 76.7% to 94.7% lower.

A systematic review and meta-analysis provide insight into the risks of precocious puberty and early menarche based on consumption of a soy-based infant diet.

A recent systematic review and meta-analysis provide a deep dive into the effectiveness of pelvic ultrasonography as a complementary tool to GnRH testing for differentiating between precocious puberty and premature thelarche.

The standard of care for managing high cholesterol levels.

The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.

With the aim of confronting racism and inequities in care and within the workforce, the Endocrine Society released a statement addressing racism within endocrinology on January 13.

An analysis of data from 1860 mother-child pairs suggests presence of abnormal maternal thyroid hormone levels could help in the prediction of behavioral and emotional health problems in male offspring at 4 years of age.

The estimated prevalence of diabetes increased from 10.9% in 2013 to 12.4% in 2018, without a significant improvement seen in adequate treatment.

Announced on December 30, the approval of levoketoconazole (Recorlev), a cortisol synthesis inhibitor, is for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative.

Data show Asian, Black, and Hispanic patients and those with lower income were less likely to receive treatment with GLP-1 RAs.